Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)
Stephen I. Katz grant supports innovative research projects from early-stage investigators without preliminary data; includes basic experimental studies involving humans but not specific applications or clinical trials.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: May 28, 2025 (New) | June 26, 2025 (Renewal/Resubmission/Revision) | August 26, 2025 (AIDS) | September 26, 2025 (New) | October 28, 2025 (Renewal/Resubmission/Revision) | December 28, 2025 (AIDS)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.
Summary: Supports early stage investigators proposing innovative, basic experimental studies with humans that represent a change in research direction and do not include preliminary data.
Key Information: Applications must not include preliminary data; a one-page attachment describing the change in research direction is required.
Description
This opportunity supports Early Stage Investigators (ESIs) in launching innovative research projects that represent a significant change in research direction, specifically in basic experimental studies involving humans. The program is designed for projects where no preliminary data exist, and applications must not include any unpublished data. The proposed research must align with the scientific missions of one or more participating NIH Institutes or Centers and must meet the NIH definition of both a clinical trial and basic research.
The Katz award is intended to encourage ESIs to pursue bold, novel directions that are distinct from their prior work or training, stimulating innovation and new approaches in biomedical and behavioral research. Projects should focus on understanding fundamental aspects of phenomena in humans, without specific application toward processes or products.
